Skip to main content
DMRA logo
DMRA
(NASDAQ)
Damora Therapeutics, Inc.
$29.17-- (--)
Loading... - Market loading

Damora Therapeutics (DMRA) Stock Price & Financial Analysis

Damora Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$28.25 - $30.75
52-Week High$38.33
52-Week Low$2.45
Open$29.28
Volume488.96K
Average Volume (3M)803.21K
Market Cap38.71M
Shares Outstanding1.33M
Price to Book (P/B)0.08
EV/EBITDA2.09
50-Day MA$25.36
200-Day MA$23.25
52-Week Change668.64%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Damora Therapeutics

What is the current stock price for DMRA?

As of the latest trading session, DMRA stock trades at $29.17. The 52-week range is $2.45–$38.33, with a day range of $28.25–$30.75.

What is the P/E ratio for DMRA?

The P/E ratio (Price-to-Earnings) for DMRA is shown in the Key Statistics section. This valuation metric helps compare Damora Therapeutics, Inc. to industry peers.

Does DMRA pay dividends?

Damora Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for DMRA?

Based on 7 analysts, the consensus for DMRA is Buy.

What is the market cap of DMRA?

Damora Therapeutics's market capitalization is $38.7M, classifying it as a micro-cap company. Damora Therapeutics operates in the Healthcare sector within the Biotechnology industry.